Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?

[1]  I. Fridovich,et al.  The role of O2.- in the production of HO.: in vitro and in vivo. , 1994, Free radical biology & medicine.

[2]  M. Burt,et al.  Iron and coronary heart disease. , 1993, BMJ.

[3]  B. Halliwell,et al.  Inhibition of mammalian 5-lipoxygenase and cyclo-oxygenase by flavonoids and phenolic dietary additives. Relationship to antioxidant activity and to iron ion-reducing ability. , 1991, Biochemical pharmacology.

[4]  B. Halliwell,et al.  DNA and free radicals , 1993 .

[5]  B. Babior,et al.  Chronic granulomatous disease. , 1990, Advances in human genetics.

[6]  H. Ischiropoulos,et al.  Oxidative chemistry of peroxynitrite. , 1994, Methods in enzymology.

[7]  E. Feskens,et al.  Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study , 1993, The Lancet.

[8]  J. Doroshow,et al.  Phospholipid hydroperoxide glutathione peroxidase is the 18-kDa selenoprotein expressed in human tumor cell lines. , 1991, The Journal of biological chemistry.

[9]  B Chance,et al.  Hydroperoxide metabolism in mammalian organs. , 1979, Physiological reviews.

[10]  E. Stadtman,et al.  Metal-catalyzed oxidation of proteins. Physiological consequences. , 1991, The Journal of biological chemistry.

[11]  D. Muller,et al.  Neurochemical, neurophysiological, and neuropathological studies in vitamin E deficiency. , 1990, Critical reviews in neurobiology.

[12]  J. Gutteridge,et al.  Free radicals in disease processes: a compilation of cause and consequence. , 1993, Free radical research communications.

[13]  J. Gutteridge,et al.  Caeruloplasmin: physiological and pathological perspectives. , 1981, Critical reviews in clinical laboratory sciences.

[14]  A. Meister.  On the antioxidant effects of ascorbic acid and glutathione. , 1992, Biochemical pharmacology.

[15]  G. Schuurhuis,et al.  Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity. , 1990, Pharmacology & therapeutics.

[16]  J. Uetrecht,et al.  Myeloperoxidase-mediated activation of xenobiotics by human leukocytes. , 1993, Toxicology.

[17]  T. Byers,et al.  Vitamin E supplements and coronary heart disease. , 2009, Nutrition reviews.

[18]  B. Halliwell,et al.  Action of biologically-relevant oxidizing species upon uric acid. Identification of uric acid oxidation products. , 1990, Chemico-biological interactions.

[19]  L. Breimer.  Invited Review: Repair of DNA Damage Induced by Reactive Oxygen Species , 1991 .

[20]  G. Hatch,et al.  Comparison of antioxidant substances in bronchoalveolar lavage cells and fluid from humans, guinea pigs, and rats. , 1993, Experimental lung research.

[21]  W. Robberecht,et al.  Rapid Communication: Cu/Zn Superoxide Dismutase Activity in Familial and Sporadic Amyotrophic Lateral Sclerosis , 1994, Journal of neurochemistry.

[22]  R. Mason,et al.  Free radicals in toxicology. , 1993, Toxicology and applied pharmacology.

[23]  S. Moncada,et al.  The L-arginine-nitric oxide pathway. , 1993, The New England journal of medicine.

[24]  B. Halliwell,et al.  The antioxidants of human extracellular fluids. , 1990, Archives of biochemistry and biophysics.

[25]  P. Lambelet,et al.  Radical exchange reactions between vitamin E, vitamin C and phospholipids in autoxidizing polyunsaturated lipids. , 1994, Free radical research.

[26]  S. Tannenbaum,et al.  Analysis of methylated and oxidized purines in urine by capillary gas chromatography-mass spectrometry. , 1989, Chemical research in toxicology.

[27]  C. Cross,et al.  Free radicals, antioxidants, and human disease: where are we now? , 1992, The Journal of laboratory and clinical medicine.

[28]  B. Halliwell,et al.  LIPID PEROXIDATION, OXYGEN RADICALS, CELL DAMAGE, AND ANTIOXIDANT THERAPY , 1984, The Lancet.

[29]  B. Halliwell,et al.  Free radicals in biology and medicine , 1985 .

[30]  D. Bredesen,et al.  INVITED COMMENTARY IS APOPTOSIS MEDIATED BY REACTIVE OXYGEN SPECIES , 1994 .

[31]  J. Morrow,et al.  A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. , 1990, Proceedings of the National Academy of Sciences of the United States of America.